Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Heyckendorf

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Nature Medicine|February 16, 2024
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trialAndreas H Diacon, Clifton E Barry, Alex Carlton, et al.
Frontiers in Immunology|October 29, 2020
Perspective for Precision Medicine for TuberculosisChristoph Lange, Rob Aarnoutse, Dumitru Chesov, et al.
Pneumologie (Stuttgart, Germany)|November 6, 2023
[Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)]Ralf Otto-Knapp, Torsten Bauer, Folke Brinkmann, et al.
Open Forum Infectious Diseases|January 31, 2019
Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control StudyMonica Sane Schepisi, Assunta Navarra, M Nieves Altet Gomez, et al.
Journal of Advanced Research|June 17, 2023
Effects of lifestyle and associated diseases on serum CC16 suggest complex interactions among metabolism, heart and lungsNathalie Rohmann, Paula Stürmer, Corinna Geisler, et al.
Respiration; International Review of Thoracic Diseases|January 8, 2026
Lung function impairment after mild SARS-CoV-2 infection in previously healthy individualsThomas Bahmer, Anne-Kathrin Ruß, Lennart Michel Reinke, et al.
Eclinicalmedicine|March 19, 2026
Long-term trends in Post-COVID severity: a machine learning analysis from the POP/COVIDOM cohort of the German NAPKON Cohort NetworkJulian Gutzeit, Martin Weiß, Thomas Bahmer, et al.
Nature Metabolism|May 12, 2025
Nicotinamide modulates gut microbial metabolic potential and accelerates recovery in mild-to-moderate COVID-19Stefan Schreiber, Georg H Waetzig, Víctor A López-Agudelo, et al.
BMC Infectious Diseases|February 21, 2024
A stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluationLucia Carratala-Castro, Willy Ssengooba, Alex Kay, et al.
Scientific Reports|May 6, 2025
Genome-wide association study of post COVID-19 syndrome in a population-based cohort in GermanyAnne-Kathrin Ruß, Stefan Schreiber, Wolfgang Lieb, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Nature Medicine|February 16, 2024
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trialAndreas H Diacon, Clifton E Barry, Alex Carlton, et al.
Frontiers in Immunology|October 29, 2020
Perspective for Precision Medicine for TuberculosisChristoph Lange, Rob Aarnoutse, Dumitru Chesov, et al.
Pneumologie (Stuttgart, Germany)|November 6, 2023
[Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)]Ralf Otto-Knapp, Torsten Bauer, Folke Brinkmann, et al.
Open Forum Infectious Diseases|January 31, 2019
Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control StudyMonica Sane Schepisi, Assunta Navarra, M Nieves Altet Gomez, et al.
Journal of Advanced Research|June 17, 2023
Effects of lifestyle and associated diseases on serum CC16 suggest complex interactions among metabolism, heart and lungsNathalie Rohmann, Paula Stürmer, Corinna Geisler, et al.
Respiration; International Review of Thoracic Diseases|January 8, 2026
Lung function impairment after mild SARS-CoV-2 infection in previously healthy individualsThomas Bahmer, Anne-Kathrin Ruß, Lennart Michel Reinke, et al.
Eclinicalmedicine|March 19, 2026
Long-term trends in Post-COVID severity: a machine learning analysis from the POP/COVIDOM cohort of the German NAPKON Cohort NetworkJulian Gutzeit, Martin Weiß, Thomas Bahmer, et al.
Nature Metabolism|May 12, 2025
Nicotinamide modulates gut microbial metabolic potential and accelerates recovery in mild-to-moderate COVID-19Stefan Schreiber, Georg H Waetzig, Víctor A López-Agudelo, et al.
BMC Infectious Diseases|February 21, 2024
A stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluationLucia Carratala-Castro, Willy Ssengooba, Alex Kay, et al.
Scientific Reports|May 6, 2025
Genome-wide association study of post COVID-19 syndrome in a population-based cohort in GermanyAnne-Kathrin Ruß, Stefan Schreiber, Wolfgang Lieb, et al.
Pageof 7